151 related articles for article (PubMed ID: 18255197)
1. QSAR study of neuraminidase inhibitors based on heuristic method and radial basis function network.
Lü WJ; Chen YL; Ma WP; Zhang XY; Luan F; Liu MC; Chen XG; Hu ZD
Eur J Med Chem; 2008 Mar; 43(3):569-76. PubMed ID: 18255197
[TBL] [Abstract][Full Text] [Related]
2. Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling.
Zhang Q; Yang J; Liang K; Feng L; Li S; Wan J; Xu X; Yang G; Liu D; Yang S
J Chem Inf Model; 2008 Sep; 48(9):1802-12. PubMed ID: 18707092
[TBL] [Abstract][Full Text] [Related]
3. QSAR study of flavonoids and biflavonoids as influenza H1N1 virus neuraminidase inhibitors.
Mercader AG; Pomilio AB
Eur J Med Chem; 2010 May; 45(5):1724-30. PubMed ID: 20116898
[TBL] [Abstract][Full Text] [Related]
4. Quantitative structure-activity relationship studies of a series of non-benzodiazepine structural ligands binding to benzodiazepine receptor.
Xia B; Ma W; Zheng B; Zhang X; Fan B
Eur J Med Chem; 2008 Jul; 43(7):1489-98. PubMed ID: 17964693
[TBL] [Abstract][Full Text] [Related]
5. On three-dimensional holographic vector of atomic interaction field analysis for influenza neuraminidase inhibitors.
Li ZS; Sun JY; Liang GZ; Lu FL; Zhu WP; Zhang MJ; Zhang Y; Yang SB; Shu M; Chen GH; Lu TT
Chem Biol Drug Des; 2009 Feb; 73(2):236-43. PubMed ID: 19207426
[TBL] [Abstract][Full Text] [Related]
6. Molecular docking and QSAR studies on substituted acyl(thio)urea and thiadiazolo [2,3-alpha] pyrimidine derivatives as potent inhibitors of influenza virus neuraminidase.
Sun J; Cai S; Mei H; Li J; Yan N; Wang Q; Lin Z; Huo D
Chem Biol Drug Des; 2010 Sep; 76(3):245-54. PubMed ID: 20626407
[TBL] [Abstract][Full Text] [Related]
7. 3D QSAR and docking study of flavone derivatives as potent inhibitors of influenza H1N1 virus neuraminidase.
Gao L; Zu M; Wu S; Liu AL; Du GH
Bioorg Med Chem Lett; 2011 Oct; 21(19):5964-70. PubMed ID: 21843936
[TBL] [Abstract][Full Text] [Related]
8. Pharmacophore modeling, 3D-QSAR studies, and in-silico ADME prediction of pyrrolidine derivatives as neuraminidase inhibitors.
Zhang J; Pan X; Wang C; Wang F; Li P; Xu W; He L
Chem Biol Drug Des; 2012 Mar; 79(3):353-9. PubMed ID: 22222003
[TBL] [Abstract][Full Text] [Related]
9. Quantitative structure activity relationship studies on thiourea analogues as influenza virus neuraminidase inhibitors.
Nair PC; Sobhia ME
Eur J Med Chem; 2008 Feb; 43(2):293-9. PubMed ID: 17513019
[TBL] [Abstract][Full Text] [Related]
10. Multiple field three dimensional quantitative structure-activity relationship (MF-3D-QSAR).
Du QS; Huang RB; Wei YT; Du LQ; Chou KC
J Comput Chem; 2008 Jan; 29(2):211-9. PubMed ID: 17559075
[TBL] [Abstract][Full Text] [Related]
11. Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function.
Schormann N; Senkovich O; Walker K; Wright DL; Anderson AC; Rosowsky A; Ananthan S; Shinkre B; Velu S; Chattopadhyay D
Proteins; 2008 Dec; 73(4):889-901. PubMed ID: 18536013
[TBL] [Abstract][Full Text] [Related]
12. Combining docking, scoring and molecular field analyses to probe influenza neuraminidase-ligand interactions.
Abu Hammad AM; Afifi FU; Taha MO
J Mol Graph Model; 2007 Sep; 26(2):443-56. PubMed ID: 17360207
[TBL] [Abstract][Full Text] [Related]
13. Development of migration models for acids in capillary electrophoresis using heuristic and radial basis function neural network methods.
Xue C; Yao X; Liu H; Liu M; Hu Z; Fan B
Electrophoresis; 2005 Jun; 26(11):2154-64. PubMed ID: 15852353
[TBL] [Abstract][Full Text] [Related]
14. Study on molecular mechanism and 3D-QSAR of influenza neuraminidase inhibitors.
Yi X; Guo Z; Chu FM
Bioorg Med Chem; 2003 Apr; 11(7):1465-74. PubMed ID: 12628672
[TBL] [Abstract][Full Text] [Related]
15. Neuraminidase pharmacophore model derived from diverse classes of inhibitors.
Zhang J; Yu K; Zhu W; Jiang H
Bioorg Med Chem Lett; 2006 Jun; 16(11):3009-14. PubMed ID: 16530411
[TBL] [Abstract][Full Text] [Related]
16. Pharmacophore modeling, quantitative structure-activity relationship analysis, and shape-complemented in silico screening allow access to novel influenza neuraminidase inhibitors.
Abu Hammad AM; Taha MO
J Chem Inf Model; 2009 Apr; 49(4):978-96. PubMed ID: 19341295
[TBL] [Abstract][Full Text] [Related]
17. Validated quantitative structure-activity relationship analysis of a series of 2-aminothiazole based p56(Lck) inhibitors.
Li J; Du J; Xi L; Liu H; Yao X; Liu M
Anal Chim Acta; 2009 Jan; 631(1):29-39. PubMed ID: 19046675
[TBL] [Abstract][Full Text] [Related]
18. Fragment-based quantitative structure-activity relationship (FB-QSAR) for fragment-based drug design.
Du QS; Huang RB; Wei YT; Pang ZW; Du LQ; Chou KC
J Comput Chem; 2009 Jan; 30(2):295-304. PubMed ID: 18613071
[TBL] [Abstract][Full Text] [Related]
19. Quantitative structure-lambda(max) relationship study on flavones by heuristic method and radial basis function neural network.
Liu H; Wen Y; Luan F; Gao Y; Li X
Anal Chim Acta; 2009 Sep; 649(1):52-61. PubMed ID: 19664462
[TBL] [Abstract][Full Text] [Related]
20. On the structure-based design of novel inhibitors of H5N1 influenza A virus neuraminidase (NA).
Mitrasinovic PM
Biophys Chem; 2009 Mar; 140(1-3):35-8. PubMed ID: 19117662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]